Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
39.14
-0.25 (-0.63%)
Dec 20, 2024, 4:00 PM EST - Market closed
Amphastar Pharmaceuticals Revenue
Amphastar Pharmaceuticals had revenue of $191.21M in the quarter ending September 30, 2024, with 5.90% growth. This brings the company's revenue in the last twelve months to $723.55M, up 20.33% year-over-year. In the year 2023, Amphastar Pharmaceuticals had annual revenue of $644.40M with 29.14% growth.
Revenue (ttm)
$723.55M
Revenue Growth
+20.33%
P/S Ratio
2.62
Revenue / Employee
$410,874
Employees
1,761
Market Cap
1.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 644.40M | 145.41M | 29.14% |
| Dec 31, 2022 | 498.99M | 61.22M | 13.98% |
| Dec 31, 2021 | 437.77M | 87.92M | 25.13% |
| Dec 31, 2020 | 349.85M | 27.49M | 8.53% |
| Dec 31, 2019 | 322.36M | 27.69M | 9.40% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harmony Biosciences Holdings | 681.88M |
| Supernus Pharmaceuticals | 651.97M |
| UFP Technologies | 461.85M |
| Galapagos NV | 290.09M |
| ImmunityBio | 7.33M |
| CG Oncology | 684.00K |
AMPH News
- 24 days ago - Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference - Accesswire
- 5 weeks ago - Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference - Accesswire
- 6 weeks ago - Amphastar Pharmaceuticals Inc. (AMPH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024 - Accesswire
- 7 weeks ago - Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024 - Accesswire
- 2 months ago - Amphastar Pharmaceuticals Inc (AMPH) Trading Down 3.54% on Oct 2 - GuruFocus
- 3 months ago - Amphastar Pharmaceuticals Offers Interesting Growth And Income Prospects - Seeking Alpha
- 4 months ago - Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference - Accesswire